| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Nippon India Nifty Pharma ETF |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.03 |
| Equity |
99.90 |
| Trep |
0.13 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
56.68% |
| Top 10 Holdings |
78.90% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
99.9 |
| Cash |
0.1 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.45 |
| PE Ratio |
33.94 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
21.93 |
| DIVI LABORATORIES LTD. |
9.71 |
| Dr Reddys Laboratories Limited |
9.35 |
| Cipla Limited |
9.04 |
| Lupin Limited |
6.65 |
| Torrent Pharmaceuticals Limited |
5.40 |
| Laurus Labs Limited |
4.98 |
| Aurobindo Pharma Limited |
4.07 |
| Alkem Laboratories Limited |
3.93 |
| Glenmark Pharmaceuticals Limited |
3.84 |
| Biocon Limited |
3.32 |
| Mankind Pharma Limited |
3.03 |
| Zydus Lifesciences Limited |
2.75 |
| IPCA Laboratories Limited |
2.53 |
| J B Chemicals and Pharma Ltd |
2.00 |
| Gland Pharma Limited |
1.73 |
| Abbott India Limited |
1.65 |
| AFebta Pharma Limited |
1.50 |
| Wockhardt Limited |
1.34 |
| Piramal Pharma Limited |
1.15 |
| Triparty Repo |
0.13 |
| Net Current Assets |
-0.03 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
